The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2009

Filed:

Nov. 10, 2003
Applicants:

Noriaki Tanaka, Asaguchi-gun, Okayama 719-0252, JP;

Naoya Kobayashi, Okayama-shi, Okayama 703-8261, JP;

Michiki Narushima, Okayama, JP;

Yoshihito Tanaka, Okayama, JP;

Inventors:

Noriaki Tanaka, Asaguchi-gun, Okayama 719-0252, JP;

Naoya Kobayashi, Okayama-shi, Okayama 703-8261, JP;

Michiki Narushima, Okayama, JP;

Yoshihito Tanaka, Okayama, JP;

Assignees:

Other;

Kuraray Medical Inc., Okayama, JP;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12P 5/06 (2006.01); C12P 21/06 (2006.01); C12P 21/04 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A reversibly immortalized human pancreatic islet cell line containing an hTERT gene and an SV40T gene each interposed between a pair of LoxP sequences, characterized in that it is capable of producing insulin and enhancing expression of insulin after excising the hTERT gene and the SV40T gene, in particular, NAKT-13 (deposited with International Patent Organism Depository, National Institute of Advanced Industrial Science and Technology, address: AIST Tsukuba Central 6, 1-1, Higashi 1-Chome, Tsukuba-shi, Ibaraki-ken, 305-8566 Japan, deposited date: Sep. 4, 2003, accession number: FERM BP-08461) or a passage cell line thereof; a human pancreatic islet cell obtained by excising the hTERT gene and the SV40T gene from the reversibly immortalized human pancreatic islet cell line or passage cell line thereof; and use of these cells. By using the reversibly immortalized human pancreatic islet cell line of the invention insulin-producing cells can be easily and surely obtained in a number enough to meet the demand.


Find Patent Forward Citations

Loading…